JP, utilizing my expertise that some on here are jealous of, there might not be any need for publicizing Lympro as we would like to see for the sole reason that Amarantus has already had face to face meetings with the end users/KOLs and that was all that was needed to know they are eager to use it. At the end of the day, it is those KOLs that need to be impressed with Lympro and utilize it en masse to put revenue on Amarantus' books. That beats any national headline. But that's my expert opinion.
Best regards,
BE living in someone's head rent free.
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links
My Agenda: To see Amarantus prosper so I can make a nice return on my investment.